Studies of gene and protein expression have shown that alternative splicing of multiple BCL2 family members facilitate the expansion of quiescent CML stem cells [99, 100] and reduce their apoptotic rate [101]. Here, BCL2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.